{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:37Z","timestamp":1787027017336,"version":"build-2736575974"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.01198","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:14:26Z","timestamp":1573517666000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Database"],"prefix":"10.3389","volume":"9","author":[{"given":"Xuejiao","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoshuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1200\/JCO.2018.36.15_suppl.1568","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study","volume":"4","author":"Fitzmaurice","year":"2018","journal-title":"JAMA Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1182\/blood-2006-11-051672","article-title":"Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)","volume":"110","author":"Morton","year":"2007","journal-title":"Blood."},{"key":"B3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1023\/A:1008282818705","article-title":"Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas","volume":"8","author":"Zucca","year":"1997","journal-title":"Ann Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1200\/JCO.2005.07.155","article-title":"Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin","volume":"23","author":"Lopez-Guillermo","year":"2005","journal-title":"J Clin Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1158\/1055-9965.EPI-15-0921","article-title":"Contributions of subtypes of non-hodgkin lymphoma to mortality trends","volume":"25","author":"Howlader","year":"2016","journal-title":"Cancer Epidemiol Biomark Prevent."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","article-title":"Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia","volume":"23","author":"Sehn","year":"2005","journal-title":"J Clin Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3109\/10428194.2014.982636","article-title":"Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era","volume":"56","author":"Lu","year":"2015","journal-title":"Leuk Lymphoma."},{"key":"B8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/bjh.15444","article-title":"Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement","volume":"185","author":"Chihara","year":"2018","journal-title":"Br J Haematol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ajh.23638","article-title":"Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database","volume":"89","author":"Castillo","year":"2014","journal-title":"Am J Hematol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3109\/10428194.2011.557167","article-title":"Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines","volume":"52","author":"Link","year":"2011","journal-title":"Leuk Lymphoma."},{"key":"B11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"International","year":"1993","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1200\/JCO.1996.14.7.2131","article-title":"Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study","volume":"14","author":"Kramer","year":"1996","journal-title":"J Clin Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1182\/blood-2016-02-629063","article-title":"CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date","volume":"127","author":"Park","year":"2016","journal-title":"Blood."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1080\/10428194.2017.1387905","article-title":"Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL","volume":"59","author":"Roberts","year":"2018","journal-title":"Leuk Lymphoma."},{"key":"B17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.beha.2018.07.011","article-title":"The promise of CAR T-cell therapy in aggressive B-cell lymphoma","volume":"31","author":"Nair","year":"2018","journal-title":"Best Pract Res Clin Haematol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","article-title":"Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma","volume":"338","author":"Wotherspoon","year":"1991","journal-title":"Lancet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-127-3-199708010-00026","article-title":"Regression of gastric lymphoma with therapy for Helicobacter pylori infection","volume":"127","author":"Seymour","year":"1997","journal-title":"Ann Intern Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1470-2045(02)00651-4","article-title":"Gastric MALT lymphoma: from aetiology to treatment","volume":"3","author":"Du","year":"2002","journal-title":"Lancet Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJM200404153501619","article-title":"Immunoproliferative small intestinal disease associated with Campylobacter jejuni","volume":"350","author":"Peterson","year":"2004","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon","year":"1993","journal-title":"Lancet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1073274818778256","DOI":"10.1177\/1073274818778256","article-title":"Primary gastric lymphoma, epidemiology, clinical diagnosis, and treatment","volume":"25","author":"Juarez-Salcedo","year":"2018","journal-title":"Cancer Control."},{"key":"B24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/annonc\/mdl378","article-title":"Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?","volume":"18","author":"Di Raimondo","year":"2007","journal-title":"Ann Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s002770000201","article-title":"Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association?","volume":"79","author":"Genvresse","year":"2000","journal-title":"Ann Hematol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/1097-0142(20011015)92:8<2023::AID-CNCR1540>3.0.CO;2-B","article-title":"Primary hepatic lymphoma: favorable outcome after combination chemotherapy","volume":"92","author":"Page","year":"2001","journal-title":"Cancer."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1182\/blood-2010-05-283358","article-title":"Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo","volume":"116","author":"Kasama","year":"2010","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.critrevonc.2014.07.004","article-title":"Reproductive factors and non-Hodgkin lymphoma: a systematic review","volume":"92","author":"Costas","year":"2014","journal-title":"Crit Rev Oncol. Hematol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/1055-9965.EPI-08-1118","article-title":"Sex disparities in cancer incidence by period and age","volume":"18","author":"Cook","year":"2009","journal-title":"Cancer Epidemiol Biomark Prevent."},{"key":"B30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/10428190701809156","article-title":"Prognostic factors in patients with diffuse large B cell lymphoma: before and after the introduction of rituximab","volume":"49","author":"Ngo","year":"2008","journal-title":"Leuk Lymphoma."},{"key":"B31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1600-0609.2010.01541.x","article-title":"Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy","volume":"86","author":"Riihijarvi","year":"2011","journal-title":"Eur J Haematol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)","volume":"9","author":"Pfreundschuh","year":"2008","journal-title":"Lancet Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1182\/blood-2011-09-380949","article-title":"The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL","volume":"119","author":"M\u00fcller","year":"2012","journal-title":"Blood."},{"key":"B34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12885-017-3414-2","article-title":"The dose-response relationship between tobacco smoking and the risk of lymphomas: a case-control study","volume":"17","author":"Taborelli","year":"2017","journal-title":"BMC Cancer."},{"key":"B35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2015.07.004","article-title":"Microenvironment abnormalities and lymphomagenesis: immunological aspects","volume":"34","author":"Taylor","year":"2015","journal-title":"Semin Cancer Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmi008","article-title":"Sex hormones and the immune response in humans","volume":"11","author":"Bouman","year":"2005","journal-title":"Hum Reprod Update."},{"key":"B37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1749-6632.2009.05383.x","article-title":"The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases","volume":"1193","author":"Cutolo","year":"2010","journal-title":"Ann NY Acad Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/oxfordjournals.aje.a117725","article-title":"Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults","volume":"142","author":"Replogle","year":"1995","journal-title":"Am J Epidemiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/sj.bjc.6602297","article-title":"The age distribution of cancer and a multi-stage theory of carcinogenesis","volume":"91","author":"Armitage","year":"2004","journal-title":"Br J Cancer."},{"key":"B40","doi-asserted-by":"publisher","first-page":"E289","DOI":"10.3390\/v9100289","article-title":"Telomere dynamics in immune senescence and exhaustion triggered by chronic viral infection","volume":"9","author":"Bellon","year":"2017","journal-title":"Viruses."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"B42","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein-Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2141.2008.06988.x","article-title":"Recent advances in the understanding and management of diffuse large B-cell lymphoma in children","volume":"142","author":"Reiter","year":"2008","journal-title":"Br J Haematol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/10428194.2012.708751","article-title":"Examining racial differences in diffuse large B-cell lymphoma presentation and survival","volume":"54","author":"Flowers","year":"2013","journal-title":"Leuk Lymphoma."},{"key":"B45","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.anl.2018.05.006","article-title":"Extranodal involvement of diffuse large B-cell lymphoma in the head and neck: an indicator of good prognosis","volume":"46","author":"Lee","year":"2019","journal-title":"Auris Nasus Larynx."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.humpath.2015.05.007","article-title":"Extranodal hematopoietic neoplasms and mimics in the head and neck: an update","volume":"46","author":"Thakral","year":"2015","journal-title":"Hum Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.clon.2003.10.010","article-title":"Localised extranodal lymphoma of the head and neck: the Sheffield Lymphoma Group experience (1971-2000)","volume":"16","author":"Hart","year":"2004","journal-title":"Clin Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0009-9260(85)80184-7","article-title":"Extranodal lymphoma of the head and neck: a review of 49 consecutive cases","volume":"36","author":"McGurk","year":"1985","journal-title":"Clin Radiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3109\/10428194.2010.504872","article-title":"Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"51","author":"Hui","year":"2010","journal-title":"Leuk Lymphoma."},{"key":"B50","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1186\/s12885-016-2684-4","article-title":"Nomograms to predict survival after colorectal cancer resection without preoperative therapy","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Cancer."},{"key":"B51","doi-asserted-by":"publisher","first-page":"950","DOI":"10.7150\/jca.17370","article-title":"Comparison of prognostic nomograms based on different nodal staging systems in patients with resected gastric cancer","volume":"8","author":"Wang","year":"2017","journal-title":"J Cancer."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:14:30Z","timestamp":1573517670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":51,"alternative-id":["10.3389\/fonc.2019.01198"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.01198","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"article-number":"1198"}}